Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection

Completed · Phase 2 · Has a placebo group

Conditions studied: HIV -1 Infection, HIV Infections

In brief

The purpose of this study is: 1. To assess the antiviral activity of PRO 140 2. To assess the safety and tolerability of PRO 140 3. To generate additional PK, PD and safety data of PRO 140

Key facts

Study ID

NCT00642707

Run by

CytoDyn, Inc.

People needed

44

Starts

2008-03-01

Expected to finish

2008-11-01

Last updated by the study team

2016-01-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males \& females, age ≥ 18 years (or minimum adult age as determined by local regulatory authorities)
• Screening plasma HIV-1 RNA ≥ 5,000 copies/mL
• CD4+ lymphocyte cell count ≥ 300 cells/mm3 and no documented count < or = 250 cells/mm3
• Has not taken any antiretroviral therapy (ART) w/in 12 wks of Early Screening Visit
• Exclusive CCR5-tropic virus as determined by Trofile™ Assay at Early Screening Visit
• Clinically normal or "not clinically significant (NCS)" resting electrocardiogram
• Women of reproductive potential must have a negative serum pregnancy test at Late Screening Visit \& a negative urine pregnancy test w/in 72 hrs prior to first dose of study medication, \& be non-lactating. Male \& female subjects must agree not to participate in a conception process from Early Screening Visit through Day 59.

You may not qualify if…

• CXCR4 tropic virus or dual/mixed tropic (R5X4) virus determined by the Trofile™ Assay.
• Females who are pregnant, lactating or breastfeeding, or who plan to become pregnant during the study.
• History of active hepatitis within the previous 24 wks
• Prior use of any entry, attachment, CCR5 co-receptor or fusion inhibitor, including PRO 140, experimental or approved.
• Any immunization or vaccination (including influenza vaccine) within 30 days prior to administration of study drug.

Where it is running

• Progenics Pharmaceuticals, Inc. — Tarrytown, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.